Zenith Drugs Ltd PE Ratio

Zenith Drugs PE Ratio

Image

Zenith Drugs Ltd

NSE: Zenith

PE

7.4

Last updated on: Apr 21, 2026

Key Highlights

  • The P/E Ratio of Zenith Drugs Ltd is 7.4 as of 21 Apr 26 The P/E Ratio of Zenith Drugs Ltd changed from 11.2 on March 2024 to 11.2 on March 2024 . This represents a CAGR of 0.00% over 1 years The Latest Trading Price of Zenith Drugs Ltd is ₹ 40.6 as of 05 Jun 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.3 in 5 years. This represents a CAGR of 5.60% The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 26.5. The PE Ratio of IT - Software industry is 17.9. The PE Ratio of Pharmaceuticals industry is 40.9. The PE Ratio of Retail industry is 67.8. The PE Ratio of Textiles industry is 53.9 in 2025 .

Historical P/E Ratio of Zenith Drugs Ltd

No data available

Company Fundamentals for Zenith Drugs Ltd

Image

Zenith Drugs Ltd

NSE: Zenith

Share Price

₹ 40.6

-1.10 (-2.64%)

stock direction

Last updated on: Jun 05, 2026

Market Price of Zenith Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Zenith Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Jun 202640.6
04 Jun 202641.7
03 Jun 202640.1
02 Jun 202641.9
01 Jun 202643.6
29 May 202647.95
27 May 202645.45
26 May 202646.45
25 May 202640
22 May 202638.95

SWOT Analysis Of Zenith Drugs Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Zenith Drugs Ltd

Asset Value vs Market Value of Zenith Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Zenith Drugs Ltd Explained

69.62

Market cap

7

Earnings

16.8X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Zenith Drugs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Zenith Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Zenith Drugs Ltd

No data available

* All values are in %

About Zenith Drugs Ltd

  • Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company as 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
  • Subsequently, Company was converted into Public Limited and consequently, the name of the Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
  • Zenith's core business centers on production of high-quality, cost-effective pharmaceutical formulations such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.
  • With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.

Zenith Drugs Ltd News Hub

Zenith Drugs to convene AGM

Zenith Drugs announced that the 24th Annual General Meeting (AGM) of the company will be held on 25

Read more

02 Sept 24

Zenith Drugs to table results

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powere

Read more

11 Nov 24

Zenith Drugs to hold board meeting

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 12 April 2025. Powered

Read more

04 Apr 25

Zenith Drugs to hold board meeting

Zenith Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2025. Powered by

Read more

24 May 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions